We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Stain-Free Imaging Platform Matches Standard Cancer Pathology

By LabMedica International staff writers
Posted on 16 Jun 2026

Histopathology underpins cancer diagnosis, but turnaround times and inter-laboratory variability can limit timely, consistent interpretation. More...

Conventional staining relies on chemical dyes and multiple preparation steps that add time and may affect image quality. A new study shows that a stain-free platform can generate diagnostic images comparable to standard staining while accelerating workflow and supporting algorithm development.

King Abdullah University of Science and Technology (KAUST; Thuwal, Saudi Arabia) has developed a stain-free imaging platform designed to analyze tissue samples more quickly and consistently. The approach replaces dyes with engineered silicon slides that produce detailed structural color images directly from tissue, enabling immediate microscopic assessment. The images are suitable for pathologist review and generate standardized digital data that could support future AI-assisted diagnosis.

The platform was first validated on colorectal tissue, a priority disease area in Saudi Arabia. In a head-to-head evaluation against conventional pathology, the stain-free method achieved 99% agreement in diagnostic conclusions for colorectal specimens. The study assessed tissue from 120 patients and found strong concordance in identifying healthy and cancerous features, while early results indicated a 40–50% reduction in sample preparation time compared with standard workflows.

The research is published in Advanced Science and aligns with KAUST’s Smart Health mission to advance technologies for cancer prevention, diagnosis, and treatment. KAUST is collaborating with King Faisal Specialist Hospital & Research Centre (KFSHRC) Madinah to further evaluate the platform across broader healthcare settings in Saudi Arabia. 

In addition to colorectal samples, tests on breast, lung, and thyroid tissues captured key histological features comparable to conventionally stained slides, supporting additional validation efforts. The team states the system was developed with practical deployment in mind and will continue to be assessed for clinical and commercial pathways.

“This research focuses on improving one of the most important steps in diagnosis: how tissue samples are prepared and reviewed,” said Qiaoqiang Gan, Professor of Material Science and Engineering at KAUST. “Traditional staining methods can be influenced by preparation steps, reagent quality, and laboratory conditions. By generating consistent digital images without dyes, we can reduce variability and create data that is more reliable for both clinical review and future AI-assisted analysis.”

Related Links
KAUST


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

New Insights Into Fetal DNA Could Improve Non-Invasive Prenatal Testing

Non-invasive prenatal testing is widely used to screen pregnancies for genetic conditions by analyzing DNA fragments in maternal blood. Although it offers a safer alternative to invasive procedures such... Read more

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.